Study Finds Vaginal Ring Can Decrease the Risk of HIV Infection
It was recently found through a study by the International Partnership for Microbicides, the vaginal ring which releases an experimental anti-AIDS drug called dapirivine can decrease the risk of HIV infection by 27-31 percent in all women and 37-61 percent in women over the age of 65.
The ring is worn for four weeks and then removed, and two studies were conducted on 4, 588 women in African countries such as Malawi, South Africa, Uganda and Zimbabwe. What was not determined was if the vaginal ring had more of an effect on women over 25 due to biological reasons or because they were more likely to use it properly.
The CEO of the International Partnership for Microbicides, Zeda Rosenberg, feels the vaginal holds significant importance in countries with high rates of HIV because the women there feel like they aren’t in a position to ask their partners to use condoms.
The women need a form of HIV prevention they can use on their own and will protect them from being infected and is also easy to use.